A Double Blind Study Comparing Low Dose and High Dose IV Esomeprazole After Successful Endoscopic Therapy in Patients With Peptic Ulcer Bleeding.

Trial Profile

A Double Blind Study Comparing Low Dose and High Dose IV Esomeprazole After Successful Endoscopic Therapy in Patients With Peptic Ulcer Bleeding.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Esomeprazole (Primary) ; Esomeprazole (Primary) ; Lansoprazole
  • Indications Bleeding ulcer
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Aug 2011 Actual initiation date (Aug 2011) added as reported by ClinicalTrials.gov.
    • 11 Aug 2011 Official Title amended as reported by ClinicalTrials.gov.
    • 11 Aug 2011 Planned end date changed from 1 Jan 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top